Dhaneshwar Kumar, PhD

Visiting Postdoctoral Fellow
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health
Bethesda, MD, USA


Currently, he is working as a “Visiting Postdoctoral Fellow” at the National Institutes of Health (NIH), Bethesda, MD, USA since Nov-2019. He was Graduated from the Dr. Harisingh Gour University, MP, India, with a Master of Science in Applied Microbiology & Biotechnology in May 2012 and obtained a PhD from the Indian Institute of Science Education and Research (IISER) Mohali, India, in May 2019. During this PhD program he studied CD8+ T-cell responses during herpes virus infections in mice and zebrafish. His main interest is to investigate the role of transcription factors and non-coding transcriptome in regulating the fate and functions of our immune cells (specifically T-cells and B-cells) and environmental cues that shape those transcriptomes. These studies are primarily focused to understand the response generated post viral and fungal infections and in autoimmune diseases. He is accessible over following webpages.


• (2019-Present) Postdoctoral Fellow, National Institutes of Health (NIH), MD, USA
• (2014-2019) PhD, Biological Sciences, IISER Mohali, India
• (2010-2012) MSc, Applied Microbiology and Biotechnology, Dr. Harisingh Gour University, MP, India
• (2007-2010) BSc, Biotechnology, Jiwaji University, MP, India

Research Interest

His research interests keywords: Immunology, T cell biology, B cell biology, Virology, Epigenomics, Transcriptomics (coding and non-coding transcriptomics), Next Generation Sequencing (NGS).

Scientific Activities


1. Chauss D, Freiwald T, McGregor R, et al. Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells. Nat Immunol. 2021; 1-13.
2. Yan B, Chakravorty S, Mirabelli C, et al. Host-virus chimeric events in SARS-CoV2 infected cells are infrequent and artifactual. J Virol. 2021; 95(15): e0029421. doi: 10.1128/JVI.00294-21
3. Kumar D, Sehrawat S. Divergent effects of a transient corticosteroid therapy on virus-specific quiescent and effector CD8+ T cells. Front Immunol. 2019; 10: 1521: doi: 10.3389/fimmu.2019.01521
4. Kaur M, Kumar D, Butty V, et al. Galectin-3 regulates γ-herpesvirus specific CD8 T cell immunity. iScience. 2018; 9: 101-119. doi: 10.1016/j.isci.2018.10.013
5. Sehrawat S, Kumar D, Rouse BT. Herpesviruses: Harmonious pathogens but relevant cofactors in other diseases? Front Cell Infect Microbiol. 2018; 8: 177. doi: 10.3389/fcimb.2018.00177
6. Saxena A, Upadhyay R, Kumar D, Kango N. Isolation, antifungal activity and characterization of soil actinomycetes. Journal of Scientific & Industrial Research. 2013; 72: 491-497.